CRCA vs CRCD: which held to its multiple?
Over three months against its own daily promise, CRCA finished 8.0 points short and CRCD 0.3 points short. ProShares Ultra CRCL and T-REX 2X INVERSE CRCL DAILY TARGET ETF.
CRCA returned +39.7% while 2 times CRCL's move would have been +65.3%
CRCD returned −68.2% while −2 times CRCL's move would have been −65.3%
CRCA among the 470 leveraged ETFs, long, over three months
CRCD among the 125 inverse ETFs over three months
A percentile among the 470 leveraged ETFs, long, over three months. CRCD is a percentile among the 125 inverse ETFs over three months, a different set, so the two marks are not on one scale. It is a position in a set, not a rating, and neither end of it is a recommendation. All leveraged ETFs ranked by it → How it is computed →
Performance, window by window
| Total return | Multiple would give | Difference | ||||
|---|---|---|---|---|---|---|
| Window | CRCA | CRCD | CRCA | CRCD | CRCA | CRCD |
| 1 month | −32.5% | +5.1% | −28.0% | +28.0% | −4.5 pts | −22.9 pts |
| 3 months | +39.7% | −68.2% | +65.3% | −65.3% | −25.6 pts | −2.9 pts |
| 6 months | −52.5% | −69.6% | −18.9% | +18.9% | −33.7 pts | −88.5 pts |
| 1 year | −87.8% | −89.7% | −76.0% | +76.0% | −11.7 pts | −165.7 pts |
| Since launch CRCA Aug 2025 · CRCD Sep 2025 | −92.0% | −90.6% | −92.5% | +70.6% | +0.6 pts | −161.2 pts |
CRCA and CRCD over each window. Every figure is an ETFIQ calculation with distributions reinvested. Source: ETFIQ. Open the live comparison on ETFIQ →
On the same fields
CRCA and CRCD on the same fields, as of Sep 30, 2026. Source: ETFIQ.
CRCA in plain words
Three months to Sep 30, 2026: CRCA returned +39.7% where its own daily promise gave +47.6%, 8.0 points short. Read the multiple against the whole window instead and 2 times CRCL's 32.6% implies +65.3%, which makes CRCA look 25.6 points short. 17.7 of that is daily compounding, which happens to any 2 times fund over the same path, and the rest is the fund. CRCA aims to return +2 times CRCL's move each day, then resets. Over one day it does that. Over longer, the daily results compound, so the total is not +2 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more. CRCL moved at 85% annualized over that window. That is what decides how far the two figures separate: the same fund on a calm underlying and a violent one is a different product.
CRCD in plain words
Three months to Sep 30, 2026: CRCD returned −68.2% where its own daily promise gave −67.8%, 0.3 points short. Read the multiple against the whole window instead and −2 times CRCL's 32.6% implies −65.3%, which makes CRCD look 2.9 points short. 2.5 of that is daily compounding, which happens to any −2 times fund over the same path, and the rest is the fund. CRCD aims to return -2 times CRCL's move each day, then resets. Over longer, the daily results compound, so the total is not -2 times the period's move: in a market that falls and comes back it is reliably less, and in a steady run it can be more.
Questions people ask
- Which came closer to its stated multiple, CRCA or CRCD?
- Over the window to Sep 30, 2026, CRCA finished 25.6 points from what its multiple implies and CRCD finished 2.9 points from its own, so CRCD came closer. Neither figure predicts the next window: it depends on how much the underlying moves about.
- Are CRCA and CRCD levered on the same thing?
- Yes. Both are levered on Circle Internet, CRCA at +2 times and CRCD at -2 times the daily move.
- Which one decays faster, CRCA or CRCD?
- Decay follows how much the underlying moves about. Over this window CRCA’s moved at 85% annualized and CRCD’s at 85%, so CRCA has the rougher ride and, at the same multiple, loses more to compounding.
- Can I hold CRCA or CRCD for a year?
- Both reset every day, so the multiple in the name applies to a single day and the daily results compound. Over a year the total is not the multiple times the year’s move, and in a market that falls and comes back it is reliably less. ETFIQ makes no recommendation either way.
ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement. A comparison is not a recommendation.
ETFIQ, CRCA against CRCD, data as of Sep 30, 2026. https://etfiq.com/compare/leverage/crca-vs-crcd
Free to use with attribution. Every figure is calculated from a named public source; the method is at etfiq.com/methodology.
Cite this page. ETFIQ, CRCA against CRCD, data as of Sep 30, 2026. https://etfiq.com/compare/leverage/crca-vs-crcd Free to use with attribution; the underlying files are at Open data.
Other forms
- Plain
- ETFIQ, CRCA against CRCD, data as of Sep 30, 2026. https://etfiq.com/compare/leverage/crca-vs-crcd
- APA
- ETFIQ. (Sep 30, 2026). CRCA against CRCD. Retrieved from https://etfiq.com/compare/leverage/crca-vs-crcd
- Markdown
- [CRCA against CRCD (ETFIQ, Sep 30, 2026)](https://etfiq.com/compare/leverage/crca-vs-crcd)